Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

October 31, 2025
Otsuka Medical Devices

Latest Real-World Clinical Data Demonstrate a 19.6 mmHg Reduction in Blood Pressure at 6 Months with Recor Medical’s Paradise Ultrasound Renal Denervation System
October 29, 2025
Otsuka Medical Devices

CMS Issues National Coverage Determination for Recor Medical’s Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
October 20, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
October 16, 2025
Taiho Pharmaceutical

Taiho Pharma Enters Into Exclusive License Agreement with Haihe Biopharma for PI3Kα Inhibitor Risovalisib (CYH33)
October 10, 2025
Otsuka Holdings

Otsuka Holdings Publishes “Integrated Report 2025”
October 7, 2025
Otsuka Pharmaceutical

Research on Work Productivity Among Japanese Workers Published in the Journal of Occupational Health
September 24, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical Enters Into Exploratory Collaboration with Guardant Health to Accelerate the Development of Therapies for Early-Stage, Recurrent Cancer Using Multimodal Real-World Data Including Genomic Profiling of MRD (Minimal Residual Disease)
September 20, 2025
Otsuka Pharmaceutical

Otsuka and Lundbeck Receive Complete Response Letter from U.S. FDA for sNDA of REXULTI (brexpiprazole) in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
September 19, 2025
Otsuka Pharmaceutical

Otsuka Receives Approval in Japan for NEXLETOL® as a Treatment for Hypercholesterolemia
September 16, 2025
Otsuka Pharmaceutical

POCARI SWEAT × TOKUSHIMA VORTIS Football Dream Project Phase 5 Welcomed Junior Soccer Players from the Middle East to Tokushima for International Exchange
September 10, 2025
Otsuka Pharmaceutical

Joint Research on Athletes’ Heat Acclimatization and Fluid/Nutrition Strategies at the World Athletics Championships Tokyo 25 Provide New Insights for People Involved in Sports Around the World
September 3, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Supports World Athletics Championships Tokyo 25 with POCARI SWEAT "Believe In Your Potential." is the Key Message We are Spreading to People Around the World
September 2, 2025
Otsuka HoldingsTaiho PharmaceuticalOther

Obituary: Notice Regarding the Passing of Yukio Kobayashi, Executive Advisor of Taiho Pharmaceutical
September 1, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Diagnostic Division Opens a New Laboratory in Tokyo to Advance Development of Next-Generation Medical Devices
August 27, 2025
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches the "Povidone Iodine Solution/Olanedine Solution Antiseptic Cartridges," antiseptics for external use
August 25, 2025
Otsuka Medical Devices

Otsuka Medical Devices Receives Manufacturing and Marketing Approval for Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension First in Japan
August 18, 2025
Otsuka Pharmaceutical

Research Findings on Skin Condition Fluctuations and Recommended Foods During the Menstrual Cycle
August 5, 2025
Otsuka Foods

Otsuka Foods to Relaunch “Sugoi Daizu” with New Packaging for All Products and Launch New “Unprocessed Type 200ml” Available Nationwide in Japan from September 1, 2025
August 5, 2025
Otsuka Foods

Otsuka Foods to Launch “Umami wo Ajiwau Wa no Bon Curry Kodawari-dashi no Wafu Curry” Japanese Soup Stock and Curry, the Ultimate Pairing Delicious Over Both Noodles and Rice! In stores across Japan on September 1, 2025
July 30, 2025
Otsuka Holdings

Otsuka Holdings Launches Otsuka Digital Academy to Further Accelerate the Development of Digital Human Resources
July 23, 2025
Otsuka Pharmaceutical

Free Outdoor Live Music Event “EXCITING SUMMER in WAJIKI 2025” Live Stage Will Run on Solar Power Promoting More Sustainable Event Experience
July 19, 2025
Otsuka Pharmaceutical

Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on REXULTI® (brexpiprazole) in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
July 15, 2025
Otsuka Pharmaceutical

Otsuka Acquires Worldwide Rights to Cantargia’s CAN10 for Development and Commercialization as a Potential Treatment for Autoimmune Diseases
July 11, 2025
Otsuka Holdings

Otsuka Holdings Selected as a Constituent of ESG Investment Indexes: FTSE4Good Index Series, FTSE Blossom Japan Index, and FTSE Blossom Japan Sector Relative Index
July 10, 2025
Taiho Pharmaceutical

Taiho Pharmaceutical and Taiho Oncology Announce U.S. FDA Acceptance of Supplemental New Drug Application for INQOVI® in Combination with Venetoclax to Treat Patients with Acute Myeloid Leukemia
July 9, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches Sales of POCARI SWEAT in India Expanding the Nutraceutical Business Globally
July 8, 2025
Taiho Pharmaceutical

Phase III Clinical Study with Therapeutic Drug for Duchenne Muscular Dystrophy (TAS-205) in Japan Did Not Meet Its Primary Endpoint
July 3, 2025
Otsuka Pharmaceutical

eMind, Tohoku University, and Otsuka Pharmaceutical Launch Epilepsy Smart Medical Joint Research Project (Phase II) Aiming to Start and Expand Epilepsy Treatment Support System
July 1, 2025
Otsuka Pharmaceutical

Otsuka Launches Comprehensive Support Program for Families of People with Severe Social Withdrawal (Hikikomori) in Collaboration with Hokkaido University
June 30, 2025
Otsuka Pharmaceutical

Otsuka Pharmaceutical Launches Portal for Corporate Health Services Empowering Employee Health Through Several Service Options

Otsuka Group News

First 30 results